Opus Genetics (IRD) Change in Acquisitions & Divestments (2011 - 2020)

Opus Genetics (IRD) has 8 years of Change in Acquisitions & Divestments data on file, last reported at $3.0 million in Q1 2020.

• Change in Acquisitions & Divestments for Q1 2020 came in at $3.0 million, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2020 was $6.0 million (down 45.45% YoY), and the FY2019 annual result was $12.0 million, changed 0.42% from the prior year.
• Change in Acquisitions & Divestments steadied at $3.0 million in Q1 2020 per IRD's latest filing, from $3.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $5.1 million in Q3 2016 and troughed at $960000.0 in Q1 2016.
• A 5-year average of $3.1 million and a median of $3.0 million in 2017 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2016 and 2017: Change in Acquisitions & Divestments sank 80.74% in 2016, then soared 183.33% in 2017.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $4.7 million in 2016, then slumped by 35.9% to $3.0 million in 2017, then tumbled by 33.33% to $2.0 million in 2018, then soared by 50.0% to $3.0 million in 2019, then changed by 0.0% to $3.0 million in 2020.
• Business Quant data shows IRD's Change in Acquisitions & Divestments at $3.0 million in Q1 2020, $3.0 million in Q4 2019, and $3.0 million in Q3 2019.